overdose semaglutide symptoms FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products The Boom in New Weight

Educating patients about the signs and symptoms of kidney problems and the importance of staying hydrated can help mitigate some of the risks associated with semaglutide use

Statistical analyses were performed using paired t-test to assess outcomes before and after pharmacotherapy

The human evidence is real and uneven

Discuss your specific fracture risk with your licensed healthcare provider before and during any GLP-1 treatment

The broader TRIUMPH clinical trial program has enrolled more than 5,800 participants across studies examining retatrutide for obesity, overweight, obstructive sleep apnea, knee osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease